Healthcare Providers & Services / Medical Care Facilities
Strategic Profile
Ramsay maintains market dominance in Australia (60% of consolidated earnings) and France (30%), establishing itself as the largest private hospital group in both markets. The company leverages a diversified geographic footprint and mixed public-private funding model to drive resilience, while its 53%-owned European subsidiary (Ramsay Sante) extends its continental presence beyond the UK.
Cyborg Score Rationale
Ramsay demonstrates strong market positioning and scale as a global healthcare leader with substantial revenue and geographic diversification. However, ROIC of 2.15% significantly underperforms WACC of 4.36%, indicating capital efficiency challenges and margin pressure that limit growth momentum.
Top Insights
Global scale advantage: ~600 facilities across 10 countries with diversified revenue streams (60% Australia, 30% France) reducing geographic concentration risk
Capital efficiency headwind: ROIC of 2.15% below WACC of 4.36% suggests the company is destroying value on incremental capital deployment
Recent M&A activity: Acquired National Capital Hospital in December 2025, indicating continued growth strategy through consolidation
Market leadership: Largest private hospital group in Australia, France, and Sweden positions Ramsay as category leader in key markets
Named Competitors
UPMC — Major US-based integrated healthcare network
Northwell — Large US regional healthcare provider
Inova — US-based healthcare system operator
Healthscope — Australian private hospital operator
Recent Developments
(December 2025) Acquired National Capital Hospital, expanding Australian footprint
(February 2026) Stock trading at $26.17 with market cap of $6.04B
Open the full interactive Ramsay Health Care Limited report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.